Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xtant Medical Holdings (XTNT) Free Cash Flow (2016 - 2025)

Xtant Medical Holdings (XTNT) has disclosed Free Cash Flow for 16 consecutive years, with $4.2 million as the latest value for Q3 2025.

  • Quarterly Free Cash Flow rose 209.42% to $4.2 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $5.2 million through Sep 2025, up 129.93% year-over-year, with the annual reading at -$16.0 million for FY2024, 45.92% down from the prior year.
  • Free Cash Flow for Q3 2025 was $4.2 million at Xtant Medical Holdings, up from $910000.0 in the prior quarter.
  • The five-year high for Free Cash Flow was $4.2 million in Q3 2025, with the low at -$6.5 million in Q1 2024.
  • Average Free Cash Flow over 5 years is -$1.6 million, with a median of -$1.5 million recorded in 2022.
  • The sharpest move saw Free Cash Flow soared 947.52% in 2021, then crashed 1245.32% in 2022.
  • Over 5 years, Free Cash Flow stood at -$203000.0 in 2021, then plummeted by 1245.32% to -$2.7 million in 2022, then skyrocketed by 53.2% to -$1.3 million in 2023, then skyrocketed by 99.45% to -$7000.0 in 2024, then soared by 59842.86% to $4.2 million in 2025.
  • According to Business Quant data, Free Cash Flow over the past three periods came in at $4.2 million, $910000.0, and $87000.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.